Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
Public ClinicalTrials.gov record NCT01736397. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Study of KRX-0502 (Ferric Citrate) in Managing Serum Phosphorus and Iron Deficiency in Anemic Subjects With Stage III to V Chronic Kidney Disease Not on Dialysis
Study identification
- NCT ID
- NCT01736397
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Keryx Biopharmaceuticals
- Industry
- Enrollment
- 149 participants
Conditions and interventions
Conditions
Interventions
- Ferric Citrate Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2012
- Primary completion
- Oct 31, 2013
- Completion
- Nov 30, 2013
- Last update posted
- Oct 19, 2017
2012 – 2013
United States locations
- U.S. sites
- 20
- U.S. states
- 14
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Tempe | Arizona | — | — |
| Not listed | La Mesa | California | — | — |
| Not listed | Sacramento | California | — | — |
| Not listed | Denver | Colorado | — | — |
| Not listed | Edgewater | Florida | — | — |
| Not listed | Miami | Florida | — | — |
| Not listed | Meridian | Idaho | — | — |
| Not listed | Evergreen Park | Illinois | — | — |
| Not listed | Bethesda | Maryland | — | — |
| Not listed | Springfield | Massachusetts | — | — |
| Not listed | Detroit | Michigan | — | — |
| Not listed | Pontiac | Michigan | — | — |
| Not listed | Reno | Nevada | — | — |
| Not listed | Great Neck | New York | — | — |
| Not listed | Mineola | New York | — | — |
| Not listed | Asheville | North Carolina | — | — |
| Not listed | Wilmington | North Carolina | — | — |
| Not listed | Orangeburg | South Carolina | — | — |
| Not listed | Houston | Texas | — | — |
| Not listed | San Antonio | Texas | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01736397, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 19, 2017 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01736397 live on ClinicalTrials.gov.